Among patients coinfected with HIV and hepatitis C, cannabis use
reduced the risk for insulin resistance, according to researchers from
INSERM in France.
“This is the first longitudinal study documenting the relationship between the reduced risk of insulin resistance and cannabis use in a population particularly concerned by insulin resistance risk,” the researchers wrote in Clinical Infectious Diseases.
“The results found were robust as they were confirmed in three
sensitivity analyses, one of [these] also including patients with
M. Patrizia Carrieri, PhD, and colleagues evaluated data from the ANRS HEPAVIH CO-13 cohort, which included patients in France coinfected
with HIV and HCV. The data included patient information obtained from
self-administered questionnaires, such as HIV and HCV testing,
HIV-related symptoms, coffee consumption and drug and alcohol use in
the previous month. The questionnaires were completed every 12 months
for 60 months.
Labels: cannabis, HIV/HCV coinfection, insulin resistance